Deciding whether a missense allelic variant affects protein function is important in many contexts. We previously demonstrated that a detailed analysis of p53 intragenic conservation correlates with somatic mutation hotspots. Here we refine these evolutionary studies and expand them to the p16/Ink4a gene. We calculated that in order for 'absolute conservation' of a codon across multiple species to achieve Po0.05, the evolutionary substitution database must contain at least 3(M) variants, where M equals the number of codons in the gene. Codons in p53 were divided into high (73% of codons), intermediate (29% of codons), and low (0 codons) likelihood of being mutation hotspots. From a database of 263 somatic missense p16 mutations, we identified only four codons that are mutational hotspots at Po0.05 (>8 mutations). However, data on function, structure, and disease association support the conclusion that 11 other codons with !5 somatic mutations also likely indicate functionally critical residues, even though P>0.05. We calculated p16 evolution using amino acid substitution matrices and nucleotide substitution distances. We looked for evolutionary parameters at each codon that would predict whether missense mutations were disease associated or disrupted function. The current p16 evolutionary substitution database is too small to determine whether observations of 'absolute conservation' are statistically significant. Increasing the number of sequences from three to seven significantly improved the predictive value of evolutionary computations. The sensitivity and specificity for conservation scores in predicting disease association of p16 codons is 70-80%. Despite the small p16 sequence database, our calculations of high conservation correctly predicted loss of cell cycle arrest function in 75% of tested codons, and low conservation correctly predicted wild-type function in 80-90% of codons. These data validate our hypothesis that detailed evolutionary analyses help predict the consequences of missense amino-acid variants.
Introduction
Missense amino-acid (AA) substitutions may or may not alter protein function. Interpreting the functional consequences of missense substitutions that occur in cancer-related genes is critical in a variety of contexts: (1) in clinical cancer genetics, to decide whether or not an allelic variant is disease related; (2) in carcinogenesis research, to evaluate allelic variants of potential tumor suppressor genes; (3) interpreting single nucleotide polymorphisms (SNPs). The development of simple and reliable functional assays often lags gene identification by years. Techniques that can predict the functional consequences of a missense alteration would make an important contribution to the clinical management of hereditary cancer, to carcinogenesis research, and to the study of diseases with complex genetic features.
Comparisons of protein sequences among species are used to infer preliminary information about protein function. In evolution, sequences coding for the most critical structural or functional AA are the most highly conserved (i.e., contain fewer nonsynonymous [missense] mutations across species) because of selection pressures against functionally altered proteins (Li, 1997) . However, in tumor cells, functionally critical AA of cancer-related genes often acquire missense somatic mutations (Greenblatt et al., 1994) . Thus, evolutionarily conserved AA may serve as a surrogate to identify functionally critical AA of cancer-related genes that may be mutated in tumors.
Detailed computational analyses are rarely performed on genes associated with human diseases. Methods that have been used include (1) visual inspection of aligned AA sequences and (2) measuring AA similarity. Most AA similarity measurements use empiric weighting schemes. Every possible identity and substitution is assigned a score based on how often each AA replaces other AAs in alignments of evolutionarily-related proteins. Identities and frequently observed substitutions receive high scores, and rarely observed substitutions receive low scores (Henikoff and Henikoff, 1993) . (3) Measuring nucleic acid variation by calculating evolutionary distance, K, the number of base substitutions per nucleotide site (sub/site) between two sequences. Nonsynonymous (K a ) and synonymous (K s ) substitution distances represent missense (K a ) and silent (K s ) sub/site at coding sequences (Li, 1997) .
Mutational spectrum analysis for tumor-associated mutation 'hotspots' has been used to infer the locations of critical AA. However, statistical methods for determining a 'hotspot' are generally not applied. We have exploited the large p53 mutation database to generate and test many hypotheses regarding carcinogenesis and mutation (http://www.iarc.fr/p53/Homepage.htm, Greenblatt et al., 1994 Greenblatt et al., , 1996 . We identified 73 hotspots in p53 (Po0.05), which account for 88% of all p53 missense mutations (Walker et al., 1999a) . Although locus-specific mutation databases of other cancer-related genes generally do not contain enough mutations to calculate true hotspots with statistical significance Po0.05, smaller mutation databases do provide clues to gene function and carcinogenesis. Even hotspot lists derived from the largest mutation databases likely underestimate the total number of functionally disruptive AA changes. Conversely, we cannot presume that all observed variants in cancer-related genes abrogate protein function, since neutral polymorphic AA variants occur. We are looking for rigorous criteria that correctly interpret mutation databases to differentiate neutral from functionally important AA changes.
AAs that are absolutely conserved through evolution represent structurally or functionally important residues, although the degree of conservation that predicts this with confidence is unclear. Variables include the gene examined, the number of sequences compared, the evolutionary distances among species, the computational methods used, and the importance of absolute AA conservation versus relatively conservative substitutions. In various genetic diseases, disease-causing mutations are more likely, but not exclusively, found at absolutely conserved AAs (Miller and Kumar, 2001 ). In the Factor IX gene, mutations at residues conserved among all related proteases are more likely to result in hemophilia B than mutations at AA conserved in Factor IX, but not in related proteases, and mutations in non-conserved residues rarely cause disease (Bottema et al., 1991) . A complex relationship of Factor IX sequence and structure was observed (Wacey et al., 1994) .
We have previously explored the correlation among evolutionary conservation, somatic mutation, protein structure, and protein function (Walker et al., 1999a; Greenblatt et al., 1994 Greenblatt et al., , 2001 ) in p53. We demonstrated that for p53, conservation at the nucleotide level correlates with somatic mutation hotspots seen in cancer (Walker et al., 1999a) . We report here extension of our p53 computations and their application to the p16/Ink4a gene (OMIM designation CDKN2A). We chose to study p16 because: (1) like p53, it is frequently inactivated during carcinogenesis, so a significant mutation database exists, (2) germline mutations lead to a hereditary cancer syndrome, Familial Melanoma (FM), (3) reliable functional assays exist to measure p16-mediated cell cycle arrest, and (4) the p16 structure is known, and can be correlated with evolutionary and mutational patterns (Russo et al., 1998) . The p16 structure consists of repeated 'ankyrin' subunits containing two antiparallel helices and a loop, creating a cleft that binds cdk4 or cdk6. Additionally, the p16/ Ink4a locus is the site of an alternatively spliced protein, ARF, which uses a different first exon but shares p16 exon 2 in an alternative reading frame. ARF promotes wild-type p53 activity by binding and sequestering the p53-binding protein mdm2. This function has been attributed to ARF's first exon, which does not overlap with the p16 coding sequence (Sharpless and Depinho, 1999) .
Our hypothesis is that systematic, detailed studies of intragenic evolution, mutation, and structure can predict not only which regions but also which specific AAs are important to structure or function. The data support our hypotheses that a high degree of conservation at the individual AA level predicts functional loss and disease association, that low conservation predicts wild-type function of missense mutants, and that structural and evolutionary analyses are complementary.
Results and discussion

Measuring evolutionary conservation
How many species must be compared to be sure that 'absolute conservation' is statistically significant? This question essentially asks how to define evolutionary 'coldspots', analogous to defining significant somatic mutation 'hotspots'. For each set of homologous sequences, we can compile a database of evolutionary substitutions and the binomial distribution can be used to study their patterns (see Methods). The null hypothesis is that mutations occur randomly, that is , they are uniformly distributed among all codons. Statistically significant 'absolute conservation' at a given codon means that, under the null hypothesis, the database must contain enough evolutionary substitutions to determine that the probability that zero sequence variants would be observed at a given codon is 0.05.
If M is the number of codons in the gene: the probability that any mutation will occur at a specific codon is P ¼ 1/M; the probability that a mutation will not occur at a specific codon is P ¼ 1-(1/M); for a database of N mutations, using binomial distribution, the probability of 0 mutations at any given codon, p 0 , is
To find the desired database size (N) such that P 0 is less than some threshold value, P, the equation p53 and p16 allelic variants: evolution and function MS Greenblatt et al becomes
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For M)1, the equation is approximated by N>ÀM(log e P). This is easily solved for P ¼ 0.05; log e 0.05 ¼ À2.997. Thus, in this limit, N>3M provides a simple way to evaluate the adequacy of the size of the database. In other words, an evolutionary substitution database must be three times larger than the number of AA in the protein in order to be sufficiently large that absolute conservation of an AA is not likely to occur by chance (i.e., Po0.05 that a codon would have 0 mutations in a random distribution of 3M mutations). This formula establishes a rigorous criterion for identifying 'coldspots' for an evolutionary substitution.
For p53, with 393 codons, solving for P ¼ 0.05 yields an N of 1176 evolutionary substitutions required. The p53 evolutionary mutation database does contain enough substitutions to declare that an absolutely conserved AA is statistically significant. The first 12 sequences in GenBank totaled over 1400 substitutions, as determined using maximum parsimony. However, using nine sequences, but omitting chicken, frog, and flounder would have left less than 500 substitutions, an insufficient number to state whether a 'conserved' AA was significantly conserved. Comparing only human and mouse species, as is commonly done (IHGSC, 2001) , overestimates the degree of conservation, resulting in many 'false-positive' conserved AA. This is illustrated in Figure 1 , which compares p53 conservation patterns over a five-codon window using 12 species ( Figure 1a ) and human versus mouse only (Figure 1b) . A one-codon window resulted in even larger overestimates of 'conserved AA' (data not shown). Human-mouse comparison alone misses a more subtle pattern apparent when comparing 12 species.
For p16, with 156 codons, 466 substitutions are required to determine absolute conservation at P ¼ 0.05. We used maximum parsimony to calculate the number of substitutions among the seven sequences in GenBank in January 2001. This p16 evolutionary mutation database totals 193 AA substitutions, which is too small to be certain that a conserved codon is because of selection and not chance. Thus, structural or functional relevance cannot reliably be inferred. More p16 sequences are required to increase the data set of evolutionary substitutions so that observations of 'absolute conservation' are significant.
Which species should be compared-are the details of intragenic evolutionary conservation in distant species relevant to human cancer? The fastest way to generate a large database of evolutionary substitutions would be to sequence homologs from species from which the most variants would be expected, that is, species distant from humans and from each other. Using known p53 sequences, we addressed whether patterns observed in distant species would be relevant enough to human and mammalian biology. We compared variation in p53 from fish (six species, 905 substitutions) and tetrapods (17 species, 1118 substitutions, Figure 1c ). Patterns are virtually identical. The P value for the probability that these curves would be so highly correlated by chance, that is, the concordance of above-average versus belowaverage conservation values at each codon, is o10
À20
. This indicates that determining p53 intragenic evolution at this evolutionary distance preserves the patterns We searched for homologs of p16 using BLAST. In 1998, we identified coding sequences for all four Ink4 genes from human and mouse, p16 from opossum and p15 from rat. By January 2001, a total of seven p16 sequences were available (adding rat, platyfish, Xiphophorus helleri and X. maculatus, and pufferfish, Takafugu rubripres). Evolutionary distances were calculated from aligned sequences ( Figure 2 ). As a whole, p16 is evolving at relatively rapid rate for a mammalian protein-coding gene (Li, 1997) ; K a between mouse and human for the whole gene is 0.28870.036 sub/site, roughly twice the rate of p53. The mean K a for 1138 human mouse pairs is one-third of this value, 0.088 sub/site (Makalowski and Baguski, 1998). K a is lower for other Ink4 family members (p18 ¼ 0.037, p15 ¼ 0.061, p19 ¼ 0.086 sub/site). The third ankyrin repeat of p16 is evolving at only onetenth the rate of ankyrins 1 and 2 (K a of ankyrin 3 ¼ 0.029970.0216 sub/site, versus 0.217 and 0.294 for ankyrins 1 and 2). Increased conservation here would be expected because many cdk-binding AA occur in ankyrin 3, and because of overlap with ARF (K a of p16 sequences that overlap ARF ¼ 0.1470.03 versus non-ARF AA K a ¼ 0.4470.07).
We calculated the variation at each codon using methods that measure both AA and nucleotide variations (Methods, Figure 2 ). Figure 2a shows nucleotide conservation on a schematic linear map of p16, both codon-by-codon and averaging over a window of three codons. The three-codon window shows most clearly that the first helices of ankyrins 2 and 3 are the most conserved motifs, although highly and poorly conserved AA are distributed throughout the protein. However, Figure 2a also shows the loss of resolution of peaks and valleys at the individual AA level when a window of three versus one codon is used. These codon-by-codon data may contain important information that could be lost when averaging over larger windows.
Calculating AA conservation ( Figure 2b ) resulted in similar patterns. Figure 2b shows how intragenic patterns of conservation change as species are added to a small database. Several motifs in ankyrins 1, 3, and 4 (e.g., codons 103-113 in loop 3) that appear to be highly conserved when three sequences are compared are revealed to be much more poorly conserved when comparing seven sequences. Thus, initial speculation of 'conserved domains' based on two or three species can be false positives based on insufficient data. This finding validates our calculation (v.s.) that the p16 evolutionary substitution database is too small. In summary, optimal resolution of intragenic patterns at the individual AA level requires a window of one codon and a significant database of sequences to establish an adequate database of evolutionary substitutions.
Using the modeling program InsightII, we mapped conservation patterns onto the p16 structure. The first helix of each pair and the last several AAs of each bhairpin loop are exposed to the cdk binding site; helix 2 and some loop residues provide structural support. Figure 3a and b show the p16 structure colored by AA matrix score. The simplest structure-function prediction is that sequences adjacent to the cdk-binding AA in the cleft (indicated in Figure 3c and d) are most conserved. This is true mainly for ankyrins 2 and 3, for both helix and loop AA (Figure 3a) . Conservation of all helices preserves the structure important for cdk binding of Ink4 proteins. On the back of the protein, many AA in all ankyrins are absolutely conserved, in both helices and loops. Conservation patterns distant from the binding site are more difficult to interpret, possibly reflecting the size of the evolutionary database and the fact that some 'absolutely conserved' AA may be false positives. Many AAs are also presumed to stabilize the three-dimensional structure. Clusters of conserved AA exist that also could represent contact points for protein interactions. We calculated the evolutionary rates of different structural features. Helix 1 of each ankyrin is more conserved than helix 2 (K a 0.1070.04 versus 0.3070.08 sub/site). Within each loop, AAs that face the cleft or are buried within the folded structure are much more conserved than adjacent AAs that face away (K a ¼ 0.0970.06 versus 0.6570.38 sub/site). Thus, even within domains, K a at individual codons may convey structurally relevant information.
p16 Somatic mutation hotspots
We calculated p16 somatic mutation hotspots as we had for p53, using our updated database (n ¼ 263). For 263 events distributed over 156 codons, any codon with eight or more mutations would be a hotspot with P 0.05. The observed distribution of p16 mutations is shown in Figure 4 . Only four codons met the Po0.05 threshold (P114, D84, H83, D74). However, restricting the definition of a hotspot to Po0.05 clearly underestimates the number of functionally significant codons. Using a threshold of Po0.05 and the conservative Bonferroni correction result in a low negative predictive value (NPV) of this statistic.
Since the likelihood that substitutions at codons associated with fewer than eight mutations alter the p16 function, we explored criteria other than the P value to differentiate critical from noncritical codons. Using the binomial distribution, less than one codon would be expected to show seven or six mutations in a database of 263 events; two codons have seven mutations in this database, and four codons have six ( Comparing Figure 3f with b shows that diseaseassociated codons are usually highly or intermediately conserved, even on the 'back' of the protein.
The most frequently observed germline mutation is G101W (GGG>TGG). No other germline AA substitutions and no somatic mutations have been reported at codon G101. Recently, it was shown that G101W represents a single founder event; all known families carrying G101W share a common haplotype (Ciotti et al., 2000) . G101W abrogates cell cycle arrest in U2OS cells (Ruas and Peters, 1998) . We tested the hypothesis that other substitutions at G101 might not affect p16 function. We created the mutation G101R (GGG>AGG, a relatively common base substitution) by site-directed mutagenesis (Figure 5a ). We transfected U2OS cells with p16 G101R and controls, confirmed protein expression (Figure 5b) , and demonstrated that G101R induces cell cycle arrest similarly to wild-type p16 (Figure 5c ). Preliminary structural modeling does not immediately explain why G101W, but not G101R, alters function. Table 2 reports new cell cycle arrest data from our experiments. Figures 3g and h show the current map of AA with known mutant function, from published literature and our data. Figures 3g and h show that the correlation between disease-associated mutants and proven in vitro loss of cell cycle arrest is good but not perfect; and the current database of function of p16 mutants provides an incomplete picture of structurefunction relationships on the back of the protein (most of these are from the current report) and away from the binding site.
In addition to G101, AA L104 and D108 also show discordant cell cycle arrest function among different mutants (Table 2 ). Figure 5 shows wild-type activity of D108E and loss of function of L104M and D108Y, despite lower protein expression of D108E. Many other mutants reported in Table 2 also induce cell cycle arrest with comparable low expression (data not shown), indicating that the level of expression of L104M and D108Y is sufficient for this function. AA W110, at the apex of the ankyrin 3 loop, is the most C-terminal AA in p16 that contacts cdk6 (Russo et al., 1998) . However, it A20P  D84N  A20E  D84H  A20T  D84E  D84V   G35  7  G35A  A100  5  A100V  G35E  A100P  A100L   P48  6  P48L  A102  5  A102V  A102E   V51  6  V51I  D108  7  D108H  V51D  D108Y  V51A  D108N   M52  5  M52K  R112  5  R112G  M52I  R112P   D74  9  D74V  P114  18  P114L  D74N  P114S  D74A   P81  5  P81L  D116  6  D116Y  D116G   H83  11  H83Y  D116V  H83N  D116N p53 and p16 allelic variants: evolution and function MS Greenblatt et al is not well conserved, and three mutants show normal cell cycle arrest (Table 2 ). It may be that its contacts with cdk4/6 are not essential. If so, then this is an example where lack of evolutionary conservation was a better predictor of mutant function than structure, a result that contradicts conventional wisdom. More detailed modeling and biochemical studies are warranted. In summary, compiling disease-associated mutations and calculating somatic mutational spectrum hotspots identifies many functionally important AAs, but underestimates the number of functionally critical codons, and requires large mutation databases. These databases are inadequate to predict whether a new allelic variant abrogates protein function. Therefore, we looked for evolutionary statistics that might predict disease-associated codons and correlate with functional data.
Uniting computational and experimental biology: the relationship of intragenic p53 and p16 evolutions to mutation, structure, and function. We extended our previous studies of p53 intragenic evolution (Walker et al., 1999a) , looking for threshold evolutionary values for each codon that could classify codons into high and low likelihood of being a hotspot.
p53: Evolution versus hotspots: For p53, we classified K a /(K a +K s ) values, averaged over a window of five codons, into absolute, intermediate, and low conservation: K a /(K a +K s ) ¼ 0 (11 codons), ¼ 0-0.4 (226 codons), and !0.4(148 codons). This parameter correlated well with the likelihood that a codon was a somatic mutation hotspot (Table 3) . A K a of 0 over a five-codon window means that an absolutely conserved AAs is flanked by two absolutely conserved AAs on each side. Of these 11 codons, eight (73%) were hotspots, versus 29% of the 226 intermediately conserved codons. K a / (K a +K s ) was o0.2 for 67% of hotspots. NPV of the lowest of these three categories using the five-codon window was 100%; no codons with K a /(K a +K s ) >0.4 (0/148) were hotspots in the p53 mutation database. Dividing the intermediate group into K a /(K a +K s ) ¼ 0-0.2 and 0.2-0.4 provided some additional discrimination (46% versus 18% hotspots, Table 3 ).
However, averaging over a large window resulted in most codons being classified as intermediate. Averaging might mask high conservation in a codon that is surrounded by poorly conserved AA (or vice versa). The results at the individual codon level (i.e., window ¼ 1) resulted in three similarly sized sets of codons (113 codons K a /(K a +K s ) ¼ 0; 101 codons K a / (K a +K s ) ¼ 0-0.4; and 179 codons K a /(K a +K s ) >0.4). Absolute conservation was a less accurate predictor of hotspots; only 46% of codons with K a /(K a +K s ) ¼ 0 were hotspots. At the individual codon level, we found no threshold that could completely eliminate the probability that a codon was a hotspot; 7% of codons with K a /(K a +K s ) >0.4 were hotspots. We calculated the receiver operator characteristic curve (ROC) for K a / (K a +K s ) to establish the best cutoff value for predicting hotspot AA (Figure 6a) . Using a cutoff value of 0.1 gives a sensitivity of 78% and a specificity of 76%, and a cutoff value of 0.2 gives a sensitivity of 82% and a specificity of 71% in identifying hotspots.
p16: We applied these evolutionary computations to p16 to test their generalizability in predicting disease association. A codon was considered disease associated if it was a somatic mutation hotspot (Table 1) or was associated with FM. We separately assessed how well evolutionary conservation correlated with function as assessed by in vitro studies (previously published data and our results). Our data confirm our prediction that absolutely conserved codons would be the most likely to be disease associated, and that mutations at poorly conserved codons would not alter p16 function, not be mutation hotspots, and not be associated with FM (summary in Table 4 ).
p16 Conservation versus disease-association: Calculating K a /(K a +K s ) for p16 on a codon-by-codon basis, we found 62 codons to be absolutely conserved at the nucleotide level (K a (Table 3 ). The likelihood of a codon either being associated with FM or being a hotspot was higher AA score indicates the calculation of amino acid conservation using the BLOSUM62 matrix as described in the text. High scores indicate high conservation. FM indicates mutation associated with Familial Melanoma. Summary includes data from literature and from this report as described in text. Data from this report in italics (see Table 2 ). WT: wild type.
p53 and p16 allelic variants: evolution and function MS Greenblatt et al for K a /(K a +K s ) o0.2 and lower if >0.2, but 0.4 was not a threshold value for excluding clinically relevant mutations. Disease association of p16 codons with high, intermediate, and low AA matrix scores were 46, 26, and 6%. In contrast to our findings for p53, averaging these values over windows of three or five codons did not improve the prediction of whether a codon was disease associated (Table 3) . There was no difference in disease association between codons with K a /(K a +K s ) ¼ 0-0.4 versus>0.4. The difference between p53 and p16 may reflect the fact that the structural motifs in p53 are larger than the structural motifs of p16, or may simply result from the expected overestimation of p16 conserved residues. Values based on different window sizes may be important to calculate for each gene, and may give clues to the features of structural motifs. p16: Conservation versus in vitro functional assays: We assessed the correlation of evolutionary conservation with in vitro data on p16-induced cell cycle arrest. Previous studies of cdk binding and cell cycle arrest activity of p16 mutants, using a variety of methods, have resulted in a database of previously published functional data on 35 codons (Ruas and Peters, 1998; Ruas et al., 1999; Walker et al., 1999b; Yarbrough et al., 1999) . For some codons, discordant results have been reported among investigators and among different assays. Data for codons that have yielded either conflicting or equivocal results were omitted. This report adds cell cycle data for nine previously unevaluated codons, plus previously untested variants at three other codons (G101, V106, R107, Table 2, Figure 5 ). In summary, 22 codons have shown wild-type function for all tested mutants and 16 codons have shown loss of function for at least one mutant.
In all, 16 codons where mutant function had previously been tested are disease associated (either hotspots or FM associated). Cdk binding, kinase inhibitory activity, and/or growth arrest was either completely or partially eliminated in 12 of the hotspots, and for four of them results are indeterminate. Altered function was previously reported at only one of 15 mutants at nonhotspot codons, most of which appeared only once or twice in the p16 somatic mutation database. Thus, even though the small database of hotspots underestimates the total, precisely defining hotspots does appear to discriminate AAs that are targets of functionally critical changes from others that may be harmless allelic variants. Most of the mutants tested were located close to and facing the cdk binding cleft (Figure 3c) . The structure/function/evolution relationship in other regions has not been thoroughly explored.
The ROC curves for AA matrix score and K a / (K a +K s ) as predictors of functional loss are shown in Figure 6b . Both methods showed 80% sensitivity and 78% specificity. When enough sequences are compared for evolutionary computations, evolutionary values are highly predictive of functional outcome, strongly supporting our hypothesis. The number of sequences compared was much more important than the computational method in determining the predictive value. When only three p16 sequences were in the database, more than half of the codons were labeled 'absolutely conserved,' but many of these were false positives. The positive predictive value (PPV) of evolutionary scores was only about 50%, although the negative predictive value (NPV) was high. With seven sequences, PPV using the cutoff values from the ROC curves rises to 67-75% and NPV remains over 80% (Table 5) . Table 4 details how well the codon-by-codon calculations correlate with in vitro and hotspot data.
These results are valuable even when analysed in the absence of p16 structural data. Certainly integrating structure enhances the analyses. However, we provide The presence of the ARF protein as a second coding region at the p16 locus was a potential confounder of our analyses. Some AAs that do not contribute to p16 function might be invariant in order to conserve ARF residues. The fact that our approach can be applied to p16 and maintain a high predictive value despite this limitation suggests that it may easily generalize to other loci, providing a method for predicting the functional implication of SNPs.
Conclusions
In summary, we have calculated how to determine statistical significance in evolutionary conservation and validated the hypothesis that comparative sequence analysis of this depth can improve upon simple sequence alignment in predicting consequences of missense mutations. Large mutation databases are required to determine statistically significant mutation hotspots and evolutionary conservation.
p16 is evolving more rapidly than the average mammalian protein coding gene. When a small p16 evolutionary database is used, codon-by-codon evolution has a high NPV but not a high PPV. With an improved evolutionary database, our calculations of high conservation correctly predicted mutant function in 75-80% of tested codons, and low conservation correctly predicted wild-type function in over 80%. These evolutionary data are predictive even in the absence of structural data. However, structural context is relevant, since not every variant at a given codon alters p16 function. Relationships among evolution, structure, mutation, disease, and function are complex, and deserve more detailed exploration in these and other genes.
Computational methods
p16 Mutation and evolutionary databases: We validated previously reported databases of p16 somatic and germline mutations (Smith-Sorensen and Hovig, 1996; Ruas and Peters, 1998) and searched MEDLINE for papers containing the keywords p16, Pollock et al, 1996, cancer, human through September 2000. Data were included if DNA sequencing was reported. A total of 85 new somatic and 55 new germline mutations reported since 1998 were compiled. We used BLAST to search GenBank for p16 homologs using human wildtype p16 as a query, most recently in January 2001. The maximum parsimony method was used to calculate the number of evolutionary substitutions present in this data set.
Multiple sequence alignment. Nucleotide and AA sequence alignments are constructed using standard programs ClustalW and Pileup (GCG Wisconsin Package). Codon-by-codon nucleotide sequence alignments are generated based on the AA sequence alignment using a program written by Dr Bond, which utilizes a global optimal alignment algorithm to maximize matched pairs. The minimum number of evolutionary substitutions was evaluated for each codon position using the Fitch algorithm (Fitch, 1971) Phylogenetic analysis. Phylogenetic trees were constructed using the neighbor joining algorithm (Saitou and Nei, 1987) as implemented in the PHYLIP suite of programs. (Felsenstein J. (1993) . PHYLIP (Phylogeny Inference Package) version 3.6a2. Distributed by the author, Department of Genetics, University of Washington, Seattle.)
Nucleotide substitution distances between sequences. Synonymous (K s ) and nonsynonymous (K a ) nucleotide substitution distances associated with branches in phylogenetic trees are calculated using the maximum likelihood method (PAML program package). K a and K s between species were calculated both by summing the values associated with the relevant branches of the tree and by using method 1 of Ina (1995) as implemented in the program dists2, made available by Ina.
Analysis of intragenic rate variation. Intragenic AA conservation patterns were assessed by the program 'plotsimilarity' (GCG Wisconsin Package), using the weighted AA substitution matrix BLOSUM62, which assigns each codon a value between À4.0 (rarely observed substitutions) and 11 (conservation of W). We report the averages of each pairwise species comparison at each codon. Three methods are used to assess nucleotide intragenic variation: (1) K a and K s associated with sets of consecutive sets (windows) of codons are calculated using the program 'subroll' as previously described (Walker et al., 1999a) . (2) The maximum likelihood method of Yang and Kumar (PAML, Yang and Kumar, 1996; Yang, 1997) , estimating the relative rate of variation associated with each codon. The parsimony-based method, implemented in PAUP, determines the number of events associated with each codon in the multiple sequence alignment.
Structural analysis: Rendering and visualization of structures found in the GenBank Molecular Modeling Database is done using a Silicon Graphics p53 and p16 allelic variants: evolution and function MS Greenblatt et al workstation with the InsightII molecular modeling environment (MSI), GRASP, and RIBBONS programs.
Hotspot and coldspot identification
Under the null hypothesis that each of N mutations is equally likely to occur at each of M codons, the probability that L mutations will occur at a previously specified codon is given by the binomial distribution (1), and the probability that L or more mutations will occur can be calculated using the incomplete b distribution (2). Equations (3) and (4) define the probability of L and !L mutations at a specified codon, respectively, using the Bonferroni inequality. A sequential four-step application of the Bonferroni method subdivides these into increasing significance levels (a 1 ¼ 0.001, a 2 ¼ 0.01, a 3 ¼ 0.014, and a 4 ¼ 0.025; a 1 +a 2 +a 3 +a 4 ¼ 0.05): 
Coldspots are codons at which no mutations are observed, i.e., L ¼ 0. Equation (1) reduces to
In order to identify statistically significant coldspots, we calculate the size of the mutation database, N, that results in bo0.05, arranging equation (6) to N ! log e ½bð0; N; 1=MÞ log e ð1 À 1=MÞ ð7Þ log e 0.05 ¼ À2.9957, so for M1, the required database size is NX3M. The size of the database required in order to infer that any coldspot is significant at 0.05 is NXM(log e M+3).
Mutation hotspots in the p16 database were calculated as in Walker et al. (1999a) . Briefly, we identify hotspot codons by finding the smallest L such that MI 1/ M (L;NÀL+1)r0.05. For p16 and the current database, the result is 8.
Laboratory materials and methods
Plasmids: pRcCMV mammalian expression vector and control vectors containing wild-type p16 and a frameshift deletion mutant at AA 103 were provided by Dr Norman Lassam, University of Toronto. pEGFP-f (Clontech) vector encoding farnesylated green fluorescent protein (pEGFP-f ) was used as a control for cotransfected cells. Plasmids were transformed into DH5a competent cells, prepared with a BioRad Quantum Maxi-prep kit, and verified by BamHI digestion, spectrophotometrically, and by DNA sequencing.
Site-directed mutagenesis: Mutant plasmids were made using Stratagene QuickChange Site-Directed Mutagenesis Kit. 5 0 and 3 0 complementary p16 primers contain the single base substitution in the middle. Complete wild type p16 plasmid is used as template. A total of 12 rounds of PCR were performed at 951, 551, 681C temperature cycling using Pfu Turbo DNA polymerase; the parent plasmid is digested with DpnI restriction enzyme. The mutant plasmids were transformed into XL-1 Blue competent cells, prepared with Bio-Rad Quantum or Qiagen Hi-Speed Midi-prep kit, and verified with BamHI digestion, spectrophotometrically, and by DNA sequencing.
Cell cycle analysis: Plasmids were transfected into U2OS, a p16-deficient human osteosarcoma cell line, using Effectene lipid transfection reagent (Qiagen). Cotransfection was done with pEGFP-f. After 48 h, cells are harvested, ethanol fixed, and stained with propidium iodide. DNA content of cells cotransfected with pEGFP-f was determined by flow cytometry (FCM) using a Coulter EpicsXL analytical flow cytometer. The DNA content of transfected cells was calculated from the flow cytometer histogram output using the ModFit software package (Verity). Three controls (vector only, wild type p16, mutant) are included with every experiment. p16 expression was confirmed by Western blotting using a mixture of mouse monoclonal antibodies JC-2, JC-4, JC-6, and JC-8, which recognize epitopes distributed throughout the protein. U2OS cell lysates were resolved on 12% SDS-PAGE gels, transferred onto PVDF membranes, and blotted with the antibody mixture. Antibody was detected using Bio-Rad Immun-Star Chemiluminescent Protein Detection System, using an alkaline phosphatase-tagged secondary antimouse polyclonal IgG.
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